Francesco Chierigo

IRCCS Policlinico San Martino Hospital - University of Genova

Francesco Chierigo is a third year resident in Urology at IRCCS San Martino Hospital (Genova, Italy).

ACADEMIC TRAINING
- 2012-2018 - Medical School Università Vita-Salute San Raffaele, International MD Program, Milan, Italy – graduated with 110/110 cum Laude with Honors
- 2015-2018 - Extracurricular internship at Department of Urology and Urological Research Institute (URI), Università Vita-Salute San Raffaele, Milan, Italy
- 1/1/2018-30/06/2018 - Internship at the Department of Andrology, University College London Hospitals, London, UK
- 1/8/2018-31/12/2019 - Research Volunteer at Department of Urology and Urological Research Institute (URI), Università Vita-Salute San Raffaele, Milan, Italy
- 1/11/2019-Ongoing - Resident in Urology at IRCCS Ospedale Policlinico San Martino, Università di Genova, Genova, Italy
- 9/4/2020-Ongoing – European Cancer League Youth Ambassador, Member of the Research Group
- 1/1/2021-31/12/2021: Postdoctoral research fellowship at Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada

AREAS OF INTEREST: Andrology, Reconstructive Urology, Onco-urology

HOBBIES: music, photography, water and winter sports

Disclosure information not submitted.

Presentation(s):

• MP03-10: Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity

  Friday, May 13, 2022
  7:00 AM – 8:15 AM

• PD11-01: Correlation between NSAID use and detection rate in men who underwent prostate biopsy. Should we reduce the PSA cutoff for men in chronic therapy? A multicenter study.

  Friday, May 13, 2022
  1:00 PM – 1:10 PM

• MP15-20: Survival after radical prostatectomy vs. Radiation therapy in ductal carcinoma of the prostate

  Friday, May 13, 2022
  2:45 PM – 4:00 PM

• MP51-20: The association of type and number of D'Amico high-risk criteria with rates of pathologically non organ confined prostate cancer

  Sunday, May 15, 2022
  4:30 PM – 5:45 PM

• PD60-04: Survival after radical prostatectomy vs. Radiation therapy in clinical node-positive prostate cancer

  Monday, May 16, 2022
  1:30 PM – 1:40 PM